The Optimal Outcome of Suppressing Ewing Sarcoma Growth in vivo With Biocompatible Bioengineered miR-34a-5p Prodrug

Daifeng Li(Nanjing University of Posts and Telecommunications), Ai-Xi Yu(Wuhan University)
Frontiers in Oncology
February 25, 2020
10.3389/fonc.2020.00222
Cited by 9

Related Papers

No related papers found

Powered by citation graph analysis